The majority of medical schools (12 of 17) have generally weak or non-existent COI policies, and four schools had policies that were moderately restrictive.
The biggest concern, however, is the lack of education provided to medical students about the pervasiveness and effects of COI relationships with drug companies.
But this strategy was shattered by COI's engagement with international media which covered closely the activities, report and follow-up to the COI report.
So don't blanket-criticize private philanthropy because there might be (at least an appearance of) bias, COI or incompetence; public philanthropy is no better.
